Semaglutide is a medication used to treat type 2 diabetes. It belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide works by stimulating the release of insulin and reducing the production of glucagon, which helps to lower blood sugar levels in people with diabetes.
Semaglutide is available in both injectable and oral forms. The injectable form is administered once a week, while the oral form is taken once daily. The medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.
In addition to its blood sugar-lowering effects, semaglutide has been shown to promote weight loss in people with obesity. It works by reducing appetite and food intake, leading to a decrease in body weight over time.
Clinical studies have demonstrated the efficacy and safety of semaglutide in managing type 2 diabetes and obesity. Common side effects may include nausea, vomiting, diarrhea, and abdominal pain. However, these symptoms often improve over time as the body adjusts to the medication.
Overall, semaglutide is a valuable treatment option for individuals with type 2 diabetes and obesity, offering the dual benefits of improving blood sugar control and supporting weight management. It is important to consult with a healthcare professional to determine if semaglutide is the right choice for your specific medical needs.
Post time: Aug-16-2024